Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic Effects of CGRP After Glibenclamide
NCT04231617Completed
- Sponsor
- Dansk Hovedpinecenter
- Start
- Jan 2020
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of glibenclamide in migraine, sponsored by Dansk Hovedpinecenter. Primary endpoint: Changes in the arterial radialis (RA), superficiel temporal artery (STA) and middle cerebral artery (MCA). Started Jan 2020; status: completed.
02
Drugs
glibenclamide
03
Conditions
migraine
Beyond the preview
Go deeper on NCT04231617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04231617.